NorthWest Biotherapeutics Inc (NWBO)

[VikingInvest]

There are some amazing posters on this MB. I am sure they have helped a lot of nervous retail investors stayed invested in NWBO. There's also a healthy amount of cheerleaders, who might also add the the continued investing in the company.

We get amazing DD on a weekly basis and it should be evident that the phase III trial will come out with some level of success and that everyone invested in this company will end up with a tidy profit.

The problem with these message boards is that sometimes, expectations from posters start a tidal wave, because investors get carried away.

The endless predictions of the arriving of TLD news has gone completely off the track. The great discovery of things pointing towards success has been used to predict TLD dates. These events have absolutely NO influence on the timing of when we will get a TLD PR, followed by publication. They do, however, indicate success of the trial.

The much anticipated TLD PR date is completely out of the company's control. That timing is 100% in the hands of the editors of the paper, which is currently (IMHO) being written and analyzed. All the events that are happening the next 3-4 weeks does not indicate that TLD is imminent. Our annual shareholders meeting had to be held around this time. LL's speaking engagements are not because she has actively been looking for them, but because she has been invited to speak. ASCO dates have been determined last year. The MHRA certification has no influence on the peer review of the paper. These events are indicators of a positive result of the trial (with the exception of LL's speaking engagements). They are great and we should be thankful for people on this board who are constantly looking for answers and are willing to share their findings.

"TLD MAY 17"!!! and similar statements are nothing but pure speculation and unless posters are involved in the peer review editing process, are based in absolutely no facts relevant to the date we will get the TLD PR followed by publication.

We will all do great in our investments in this company, but until the paper is ready to get published in a journal, Company can only come out with sporadic news that should ease our concerns regarding the result of the phase III trial,